Lisa Smith
Investor Relations, Gilmartin Group for Mobio Medical
Replay available
Mobia Medical, Inc. (NASDAQ: MOBI) Q2 2026 earnings conference call, held 2026-08-11. Replay captured from the company's public earnings webcast.

Investor Relations, Gilmartin Group for Mobio Medical
President and Chief Executive Officer
Chief Financial Officer
Analyst, Bank of America
Analyst, JP Morgan
Analyst, BTIG
Analyst, Wolfe Research
Good afternoon and welcome to the Mobio Medical second quarter 2026 earnings conference call. At this time, all participants are on a listen-only mode. After the speaker's prepared remarks, we'll conduct a question and answer session. Please note that today's conference is being recorded. I would like to turn the call over to Lisa Smith of Gilmartin Group, Investor Relations for Mobio Medical. Lisa, please go ahead. Good afternoon and thank you for being on today's call. Joining me from Mobio Medical are Richard Foust, President and Chief Executive Officer, and Bunker Curnes, Chief Financial Officer. Earlier today, Mobia Medical issued a press release announcing financial results for the quarter ended June 30th, 2026. A copy of the press release is available on the investor relations section of the company's website. Before we begin, I would like to remind you that management will make remarks during this call that constitute forward-looking statements within the meaning of the federal securities laws and that are being made pursuant to the safe harbor provisions of the Private Securities Litigation Reform Act of 1995. Any statements made during this call that relate to expectations or predictions of future events, results, or performance including our full year 2026 revenue guidance are forward-looking statements. These statements involve material risks and uncertainties that could cause actual results or events to differ materially from those anticipated or implied by these forward-looking statements. Accordingly, you should not place undue reliance on these statements. For a full list and description of the risks and uncertainties associated with our business, please refer to the sections captioned risk factors and Management's discussion and analysis of financial...